Raju Bindu, Hoshino Yoshihiko, Belitskaya-Lévy Ilana, Dawson Rod, Ress Stanley, Gold Jeffrey A, Condos Rany, Pine Richard, Brown Stuart, Nolan Anna, Rom William N, Weiden Michael D
Department of Medicine, Bellevue Chest Service and Division of Pulmonary and Critical Care Medicine, New York University School of Medicine, 550 First Avenue, NB 7N-24, New York, NY 10016, USA.
Tuberculosis (Edinb). 2008 Jan;88(1):39-51. doi: 10.1016/j.tube.2007.07.003. Epub 2007 Oct 24.
The host response to Mycobacterium tuberculosis includes macrophage activation, inflammation with increased immune effector cells, tissue necrosis, and cavity formation, and fibrosis, distortion, and bronchiectasis. To evaluate the molecular basis of the immune response in the lungs of patients with active pulmonary tuberculosis (TB), we used bronchoalveolar lavage to obtain cells at the site of infection. Affymetrix GeneChip microarrays and cDNA nylon filter microarrays interrogated gene expression in bronchoalveolar lavage (BAL) cells from 11 healthy controls and 17 patients with active pulmonary TB. We found altered gene expression for 69 genes in TB versus normal controls that included cell surface markers, cytokines, chemokines, receptors, transcription factors, and complement components. In addition, TB BAL cell gene expression patterns segregated into 2 groups: one suggestive of a T helper type 1 (Th1) cellular immune response with increased signal transducer and activator of transcription-4 (STAT-4), interferon-gamma (IFN-gamma receptor), and monokine induced by IFN-gamma (MIG) expression with increased IFN-gamma protein levels in BAL fluid; the other group displayed characteristics of Th2 immunity with increased STAT-6, CD81, and IL-10 receptor expression. We were able to demonstrate that a Th2 presentation could change to a Th1 pattern after anti-tuberculous treatment in 1 TB patient studied serially. These gene expression data support the conclusion that pulmonary TB produces a global change in the BAL cell transcriptome with manifestations of either Th1 or Th2 immunity.
机体对结核分枝杆菌的反应包括巨噬细胞活化、免疫效应细胞增多引起的炎症、组织坏死、空洞形成以及纤维化、变形和支气管扩张。为了评估活动性肺结核(TB)患者肺部免疫反应的分子基础,我们采用支气管肺泡灌洗术在感染部位获取细胞。利用Affymetrix基因芯片微阵列和cDNA尼龙滤膜微阵列检测了11名健康对照者和17名活动性肺结核患者支气管肺泡灌洗(BAL)细胞中的基因表达。我们发现,与正常对照相比,TB患者中有69个基因的表达发生了改变,这些基因包括细胞表面标志物、细胞因子、趋化因子、受体、转录因子和补体成分。此外,TB患者BAL细胞的基因表达模式分为两组:一组提示1型辅助性T细胞(Th1)细胞免疫反应,信号转导和转录激活因子4(STAT-4)、干扰素-γ(IFN-γ受体)以及IFN-γ诱导的单核因子(MIG)表达增加,BAL液中IFN-γ蛋白水平升高;另一组表现出Th2免疫特征,STAT-6、CD81和IL-10受体表达增加。在对1例接受连续研究的TB患者进行抗结核治疗后,我们能够证明其Th2表现可转变为Th1模式。这些基因表达数据支持以下结论:肺结核会使BAL细胞转录组发生全面变化,表现为Th1或Th2免疫。